After becoming sober, the body follows a timeline healing: liver regeneration, blood pressure drops, cancer risk reduction and sleep recovery. A doctor explains.
As states cut Medicaid coverage for GLP-1 drugs, access to obesity treatment is increasingly tied to income—raising questions for both Medicaid and Medicare.
More than half of the U.S. job gains in Labor Department’s new employment report came from the healthcare sector but looming cuts in federal spending could change that.
In this week’s edition of InnovationRx, we look at the healthcare giants on Forbes new Greatest Innovators list, why Garner Health is worth $1.35 billion, and more.
As cannabis replaces alcohol, normalization is outpacing medical awareness. What rising THC use means for teens, mental health and clinical risk.
Bob Wachter’s new book explains how AI is reshaping healthcare. Here, I reflect on what it gets right, what it leaves open, and why progress comes one step at a time.
Humana reported a $796 million fourth quarter loss as the health insurer continued to grapple with high medical costs of its Medicare Advantage health plan members.
AI is becoming the nervous system of the modern health system, shifting the focus from gee-whiz demonstrations to thriving through efficiency.
Independent of FDA’s enhanced oversight, it’s clear that DTC promotion of weight loss drugs is having a moment, as companies go all in in pursuit of uptake expansion.
In this article a physician describes being diagnosed with cancer and her journey that occurred after diagnosis with colon cancer.